| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71092 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72787 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77179-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-37822-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72941 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65900-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71541 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73271 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70314 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73693 | |||
![Western Blot: Rabbit Tau mAb (HL2802) [NBP3-45161] - Non-transfected (–) and transfected (+) SK-N-SH whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Tau antibody [HL2802] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp3-45161_rabbit-tau-mab-hl2802-azide-and-bsa-free-western-blot-2942025163536..jpg "<b>Genetic Strategies Validation. </b>Western Blot: Rabbit Tau mAb (HL2802) [NBP3-45161] - Non-transfected (–) and transfected (+) SK-N-SH whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Tau antibody [HL2802] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.")
![<b>Genetic Strategies Validation. </b>Western Blot: Rabbit Tau mAb (HL2802) [NBP3-45161] - Rat tissue extract (50 ug) was separated by 7.5% SDS-PAGE, and the membrane was blotted with Tau antibody [HL2802] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp3-45161_rabbit-tau-mab-hl2802-azide-and-bsa-free-western-blot-294202516917..jpg)
![Western Blot: Rabbit Tau mAb (HL2802) [NBP3-45161] - Various tissue extracts (50 μg) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Tau antibody [HL2802] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp3-45161_rabbit-tau-mab-hl2802-azide-and-bsa-free-western-blot-2942025161213..jpg)
![Immunocytochemistry/ Immunofluorescence: Rabbit Tau mAb (HL2802) [NBP3-45161] - Tau antibody [HL2802] detects Tau protein at cytoskeleton by immunofluorescent analysis.Sample: DIV9 rat E18 primary cortical neuron cells were fixed in 4% paraformaldehyde at RT for 15 min.Green: Tau stained by Tau antibody [HL2802] diluted at 1:250.Blue: Fluoroshield with DAPI.](http://images.novusbio.com/fullsize/nbp3-45161_rabbit-tau-mab-hl2802-azide-and-bsa-free-immunocytochemistry-immunofluorescence-2942025161556..jpg)
![Immunohistochemistry: Rabbit Tau mAb (HL2802) [NBP3-45161] - Tau antibody [HL2802] detects Tau protein at cytoplasm by immunohistochemical analysis. Sample: Paraffin-embedded mouse eye. Green: Tau stained by Tau antibody [HL2802] diluted at 1:100. Red: beta Tubulin 3/ Tuj1, a neural marker, stained by beta Tubulin 3/ Tuj1 diluted at 1:500. Blue: Fluoroshield with DAPI. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min](http://images.novusbio.com/fullsize/nbp3-45161_rabbit-tau-mab-hl2802-azide-and-bsa-free-immunohistochemistry-paraffin-2942025161950..jpg)
![Western Blot: Rabbit Tau mAb (HL2802) [NBP3-45161] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Tau antibody [HL2802] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp3-45161_rabbit-tau-mab-hl2802-azide-and-bsa-free-western-blot-2942025162224..jpg)
![Tau antibody [HL2802] detects Tau protein by immunohistochemical analysis.Sample: Frozen-sectioned mouse eye.Green: Tau stained by Tau antibody [HL2802] (NBP3-45161) diluted at 1:250.Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/nbp1-32618_rabbit-polyclonal-protein-phosphatase-1-beta-antibody-immunohistochemistry-frozen-141120251855420.jpg)
![Western Blot: Cytokeratin 19 Antibody (3F8) [NBP1-48277] Analysis of extracts (35ug) from 9 different cell lines by using anti-Cytokeratin 19 monoclonal antibody.](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-3F8-Western-Blot-NBP1-48277-img0007.jpg "Western Blot: Cytokeratin 19 Antibody (3F8) [NBP1-48277] Analysis of extracts (35ug) from 9 different cell lines by using anti-Cytokeratin 19 monoclonal antibody.")
![Immunocytochemistry/Immunofluorescence: Cytokeratin 19 Antibody (3F8) [NBP1-48277] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY Cytokeratin 19.](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-3F8-Immunocytochemistry-Immunofluorescence-NBP1-48277-img0006.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (3F8) [NBP1-48277] - Staining of paraffin-embedded liver tissue using anti-Cytokeratin 19mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-3F8-Immunohistochemistry-Paraffin-NBP1-48277-img0005.jpg)
![Western Blot: Cytokeratin 19 Antibody (3F8) [NBP1-48277] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Cytokeratin 19 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Cytokeratin 19.](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-3F8-Western-Blot-NBP1-48277-img0001.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (3F8) [NBP1-48277] - Staining of paraffin-embedded Adenocarcinoma of endometrium tissue using anti-Cytokeratin 19 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-3F8-Immunohistochemistry-Paraffin-NBP1-48277-img0002.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (3F8) [NBP1-48277] - Staining of paraffin-embedded Carcinoma of kidney tissue using anti-Cytokeratin 19 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-3F8-Immunohistochemistry-Paraffin-NBP1-48277-img0003.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 19 Antibody (3F8) [NBP1-48277] - Staining of paraffin-embedded Kidney tissue using anti-Cytokeratin 19mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Cytokeratin-19-Antibody-3F8-Immunohistochemistry-Paraffin-NBP1-48277-img0004.jpg)
![Western Blot: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MRPS27.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Western-Blot-NBP2-45938-img0015.jpg "Western Blot: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MRPS27.")
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0014.jpg)
![Flow Cytometry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of HEK293T cells transfected with either overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by MRPS27 antibody.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Flow-Cytometry-NBP2-45938-img0001.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Adenocarcinoma of Human colon tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0003.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0004.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0005.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0006.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0007.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Carcinoma of Human liver tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0008.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0009.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Carcinoma of Human thyroid tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0010.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Carcinoma of Human pancreas tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0011.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0012.jpg)
![Immunohistochemistry: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunohistochemistry-NBP2-45938-img0013.jpg)
![Immunofluorescence: MRPS27 Antibody (OTI6E5) [NBP2-45938] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY MRPS27.](http://images.novusbio.com/fullsize/MRPS27-Antibody-OTI6E5-Immunofluorescence-NBP2-45938-img0002.jpg)
![Western Blot: ZEB2 Antibody [NBP1-77179] - Immunoblot for detection of protein stability of core EMT-TFs under the treatment with 20uM of MG132 for 4 h before harvested. Image collected and cropped by CiteAb from the following publication (oncotarget.com/fulltext/2825), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/ZEB2-Antibody-Western-Blot-NBP1-77179-img0014.jpg "<b>Biological Strategies Validation. </b>Western Blot: ZEB2 Antibody [NBP1-77179] - Immunoblot for detection of protein stability of core EMT-TFs under the treatment with 20uM of MG132 for 4 h before harvested. Image collected and cropped by CiteAb from the following publication (oncotarget.com/fulltext/2825), licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Western Blot: ZEB2 Antibody [NBP1-77179] - Analysis in EL4 cell lysate with antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/ZEB2-Antibody-Western-Blot-NBP1-77179-img0009.jpg)
![Immunocytochemistry/ Immunofluorescence: ZEB2 Antibody - BSA Free [NBP1-77179] - Immunofluorescence of ZEB2 in Jurkat cells with ZEB2 antibody at 20 ug/ml.Red: ZEB2 Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-2711202419333477.gif)
![Western Blot: ZEB2 Antibody [NBP1-77179] - Lysates from 293T cells transfected Flag-Zeb2 with or without HA-Fbxo45 were immunoprecipitated (IP) with anti-Flag M2 antibody, and then immunoblotted. Total lysates were also used as Input for immunoblotting analysis. Image collected and cropped by CiteAb from the following publication (oncotarget.com/fulltext/2825), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/ZEB2-Antibody-Western-Blot-NBP1-77179-img0012.jpg)
![Western Blot: ZEB2 Antibody [NBP1-77179] - The protein levels of EMT-TFs were compared between carcinoma cell lines and non- or less-malignant tumor cell lines by using Western-blot analysis. The soft agar colony transformation or migration assay was referred to distinguish malignant degree of the experimental cancer cell lines (data not shown). Malignant degree: prostate cancer cell lines, P69 < M12; breast cancer cell lines, MCF7 < MD-MBA-231; lung cancer cell lines, A549 < H1299; liver cancer cell lines, HepG2 < SMMC7721. 'kD' (kilo-dalton) means the molecular weight of protein. Image collected and cropped by CiteAb from the following publication (oncotarget.com/fulltext/2825), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/ZEB2-Antibody-Western-Blot-NBP1-77179-img0013.jpg)
![Western Blot: ZEB2 Antibody - BSA Free [NBP1-77179] - Fbxo45 induces degradation of core EMT-TFsA. Immunoblot for core EMT-TFs in 293T cells transfected Zeb1, Zeb2, Snai1, Snai2 or Twist1 with increasing amount of Fbxo45. B. Immunoblot for detecting endogenous core EMT-TFs in HeLa cells transfected with or without myc-tagged Fbxo45, & harvested after treatment with 20μM of MG132 for 4 hours. C. Immunoblot for endogenous Zeb1, Zeb2, Snai1 & Snai2 in MCF7 cells treated with indicated different concentrations of 17 beta -estrogen for 24 h in the phenol-free medium to induce the expression of endogenous Fbxo45. D. Immunoblot for endogenous core EMT-TFs in HeLa transfected with siRNAs for Fbxo45 or Pam. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25460509), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-310202415392525.jpg)
![Western Blot: ZEB2 Antibody - BSA Free [NBP1-77179] - Fbxo45 induces degradation of core EMT-TFsA. Immunoblot for core EMT-TFs in 293T cells transfected Zeb1, Zeb2, Snai1, Snai2 or Twist1 with increasing amount of Fbxo45. B. Immunoblot for detecting endogenous core EMT-TFs in HeLa cells transfected with or without myc-tagged Fbxo45, & harvested after treatment with 20μM of MG132 for 4 hours. C. Immunoblot for endogenous Zeb1, Zeb2, Snai1 & Snai2 in MCF7 cells treated with indicated different concentrations of 17 beta -estrogen for 24 h in the phenol-free medium to induce the expression of endogenous Fbxo45. D. Immunoblot for endogenous core EMT-TFs in HeLa transfected with siRNAs for Fbxo45 or Pam. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25460509), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-310202415334920.jpg)
![Western Blot: ZEB2 Antibody - BSA Free [NBP1-77179] - Fbxo45 induces degradation of core EMT-TFsA. Immunoblot for core EMT-TFs in 293T cells transfected Zeb1, Zeb2, Snai1, Snai2 or Twist1 with increasing amount of Fbxo45. B. Immunoblot for detecting endogenous core EMT-TFs in HeLa cells transfected with or without myc-tagged Fbxo45, & harvested after treatment with 20μM of MG132 for 4 hours. C. Immunoblot for endogenous Zeb1, Zeb2, Snai1 & Snai2 in MCF7 cells treated with indicated different concentrations of 17 beta -estrogen for 24 h in the phenol-free medium to induce the expression of endogenous Fbxo45. D. Immunoblot for endogenous core EMT-TFs in HeLa transfected with siRNAs for Fbxo45 or Pam. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25460509), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-310202415395947.jpg)
![Western Blot: ZEB2 Antibody - BSA Free [NBP1-77179] - Fbxo45 induces degradation of core EMT-TFsA. Immunoblot for core EMT-TFs in 293T cells transfected Zeb1, Zeb2, Snai1, Snai2 or Twist1 with increasing amount of Fbxo45. B. Immunoblot for detecting endogenous core EMT-TFs in HeLa cells transfected with or without myc-tagged Fbxo45, & harvested after treatment with 20μM of MG132 for 4 hours. C. Immunoblot for endogenous Zeb1, Zeb2, Snai1 & Snai2 in MCF7 cells treated with indicated different concentrations of 17 beta -estrogen for 24 h in the phenol-free medium to induce the expression of endogenous Fbxo45. D. Immunoblot for endogenous core EMT-TFs in HeLa transfected with siRNAs for Fbxo45 or Pam. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25460509), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-31020241535644.jpg)
![Western Blot: ZEB2 Antibody - BSA Free [NBP1-77179] - Functional domains of Fbxo45 for ubiquitination of Zeb2A. Lysates from 293T cells transfected Flag-Zeb2 with or without HA-Fbxo45 were immunoprecipitated (IP) with anti-Flag M2 antibody, & then immunoblotted. Total lysates were also used as Input for immunoblotting analysis. B. Bacterially expressed GST or GST–Fbxo45, -Fbxo45 delta F-box, -Fbxo45 delta mid, or -Fbxo45 delta SPRY fusion proteins & Glutathione-Sepharose beads were incubated with lysates of HeLa cells transfected with Zeb2, Snai1 or Snai2, respectively. The proteins associated with GST–tagged Fbxo45 forms, bound on the Glutathione-Sepharose beads were washed five times with the RIPA buffer before immunoblotting. C. Lysates from 293T cells transfected Flag-Zeb2 with HA-Fbxo45, -Fbxo45 delta mid, -Fbxo45 delta F-box or -Fbxo45 delta SPRY were immunoprecipitated with anti-Flag or anti-HA antibodies, & immunoprecipitates were resolved by SDS-PAGE for Western-blot analysis. D. U2OS cells transfected with Flag-Zeb2 & HA-Fbxo45, -Fbxo45 delta F-box or -Fbxo45 delta SPRY were stained using the primary antibodies of anti-Flag M2 or anti-HA, & the second antibodies of Alexa Fluor 568 anti-mouse or Alexa Fluor 488 anti-Rabbit, respectively. Scale: 25μm. E-I. Zeb2 ubiquitination assays by using IP expriments under different conditions: Flag-Zeb2 with or without HA-Ub (E); Flag-Zeb2 with HA-Ub WT, K48R or K63R (F); Flag-Zeb2 & HA-Ub K48-only with or without myc-Fbox45 (G); Flag-Zeb2 & HA-Ub K48-only with siRNA control, siRNAs for Fbxo45 or siRNAs for Pam (H); Flag-Zeb2 & HA-Ub with HA-Fbxo45, -Fbxo45 delta F-box or -Fbxo45 delta SPRY (I). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25460509), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-310202416163752.jpg)
![Western Blot: ZEB2 Antibody - BSA Free [NBP1-77179] - Fbxo45 is a direct target of miR-27a* that mediates EMT processesA, C. The expression levels of miR-27a* (A) & Fbxo45 mRNA (C) in P69 & M12 were shown according to the data of miRNA transcriptome sequencing & DGE sequencing, respectively [46]. TPM means transcripts per million. B. Real-time PCR in delta delta Ct methods were used to confirm the expression levels of miR-27a* in P69 & M12. One representative experiment out of three was shown. D. Fbxo45 mRNA levels in stable cell lines miR-27a*-overexpressing P69 & miR-27a*-silencing M12 (zipmiR-27a*). P69 or M12 stably infected with the same lentiviral empty vector was used as a control (ctrl). E. Fbxo45 3′-UTR wide-type or mutant form at the position where is complementary to the 5′ seed region of miR-27a* was subcloned into psiCheck2 vector. 293T cells were transfected with psiCheck2 containing WT or mutant Fbxo45 3′-UTR & miR-27a* or non-specific control vector. The Renilla luciferase activity was normalized on the constitutive activity of firefly luciferase. Data are the mean±S.E.M. of three independent experiments. F-G. Immunoblot for Fbxo45, core EMT-TFs (Zeb1, Zeb2, Twist1) & their associated EMT markers (Fibronectin, N-cadherin, Laminin C2, Vimentin & E-cadherin) in stable cell lines P69-miR-27a* or M12-zipmiR-27a* (F); Immunoblot for detection of protein stability of core EMT-TFs under the treatment with 20μM of MG132 for 4 h before harvested (G). GAPDH is for a loading control. H. Immunblot for Fbxo45, N-cadherin, E-cadherin & five core EMT-TFs in stable cell lines PC3-ctrl, PC3-miR-27a* & PC3-zipmiR-27a*. alpha -tubulin is for a loading control. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25460509), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-310202416175234.jpg)
![Western Blot: ZEB2 Antibody - BSA Free [NBP1-77179] - Fbxo45 is a direct target of miR-27a* that mediates EMT processesA, C. The expression levels of miR-27a* (A) & Fbxo45 mRNA (C) in P69 & M12 were shown according to the data of miRNA transcriptome sequencing & DGE sequencing, respectively [46]. TPM means transcripts per million. B. Real-time PCR in delta delta Ct methods were used to confirm the expression levels of miR-27a* in P69 & M12. One representative experiment out of three was shown. D. Fbxo45 mRNA levels in stable cell lines miR-27a*-overexpressing P69 & miR-27a*-silencing M12 (zipmiR-27a*). P69 or M12 stably infected with the same lentiviral empty vector was used as a control (ctrl). E. Fbxo45 3′-UTR wide-type or mutant form at the position where is complementary to the 5′ seed region of miR-27a* was subcloned into psiCheck2 vector. 293T cells were transfected with psiCheck2 containing WT or mutant Fbxo45 3′-UTR & miR-27a* or non-specific control vector. The Renilla luciferase activity was normalized on the constitutive activity of firefly luciferase. Data are the mean±S.E.M. of three independent experiments. F-G. Immunoblot for Fbxo45, core EMT-TFs (Zeb1, Zeb2, Twist1) & their associated EMT markers (Fibronectin, N-cadherin, Laminin C2, Vimentin & E-cadherin) in stable cell lines P69-miR-27a* or M12-zipmiR-27a* (F); Immunoblot for detection of protein stability of core EMT-TFs under the treatment with 20μM of MG132 for 4 h before harvested (G). GAPDH is for a loading control. H. Immunblot for Fbxo45, N-cadherin, E-cadherin & five core EMT-TFs in stable cell lines PC3-ctrl, PC3-miR-27a* & PC3-zipmiR-27a*. alpha -tubulin is for a loading control. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25460509), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-31020241616011.jpg)
![Immunocytochemistry/ Immunofluorescence: ZEB2 Antibody - BSA Free [NBP1-77179] - Immunocytochemistry of ZEB2 in Jurkat cells with ZEB2 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-2711202420285893.jpg)
![Immunocytochemistry/ Immunofluorescence: ZEB2 Antibody - BSA Free [NBP1-77179] - Immunofluorescence of ZEB2 in Jurkat cells with ZEB2 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-77179_rabbit-polyclonal-zeb2-antibody-2711202420272496.jpg)
![Western Blot: c-Myc Antibody (Myc.A7) [NBP2-37822] - Analysis using the HRP conjugate of NBP2-37822. Detection of Myc Epitope Tag was performed by loading various amounts of E. coli lysate containing a multi-epitope tagged protein per well onto a 4-20% Tris-HCl polyacrylamide gel. Proteins were transferred to a PVDF membrane and blocked with 5% BSA/TBST for at least 1 hour. The membrane was probed with an HRP-conjugated Myc Epitope Tag monoclonal antibody at a dilution of 1:1000 overnight at 4?C on a rocking platform and washed in TBS-0.1% Tween-20. Chemiluminescent detection was performed using SuperSignal West Pico.](http://images.novusbio.com/fullsize/c-Myc-Antibody-Myc-A7-Western-Blot-NBP2-37822-img0011.jpg "Western Blot: c-Myc Antibody (Myc.A7) [NBP2-37822] - Analysis using the HRP conjugate of NBP2-37822. Detection of Myc Epitope Tag was performed by loading various amounts of E. coli lysate containing a multi-epitope tagged protein per well onto a 4-20% Tris-HCl polyacrylamide gel. Proteins were transferred to a PVDF membrane and blocked with 5% BSA/TBST for at least 1 hour. The membrane was probed with an HRP-conjugated Myc Epitope Tag monoclonal antibody at a dilution of 1:1000 overnight at 4?C on a rocking platform and washed in TBS-0.1% Tween-20. Chemiluminescent detection was performed using SuperSignal West Pico.")
![Immunocytochemistry/Immunofluorescence: c-Myc Antibody (Myc.A7) [NBP2-37822] - Analysis using the DyLight 680 conjugate of NBP2-37822. Staining of HeLa cells transfected with a construct containing a Myc Epitope Tag. Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature.](http://images.novusbio.com/fullsize/c-Myc-Antibody-Myc-A7-Immunocytochemistry-Immunofluorescence-NBP2-37822-img0009.jpg)
![Flow Cytometry: c-Myc Antibody (Myc.A7) [NBP2-37822] - An intracellular stain was performed on Jurkat cells with c-Myc Antibody (Myc.A7) NBP2-37822AF488 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 10 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 488.](http://images.novusbio.com/fullsize/c-Myc-Antibody-Myc-A7-Flow-Cytometry-NBP2-37822-img0013.jpg)
![Western Blot: c-Myc Antibody (Myc.A7) [NBP2-37822] - Analysis of 1:1000 (1ug/mL) Ab dilution probed against HEK293 cells transfected with Myc-tagged protein vector; untransfected (1) and transfected (2)](http://images.novusbio.com/fullsize/c-Myc-Antibody-Myc-A7-Western-Blot-NBP2-37822-img0005.jpg)
![Western Blot: c-Myc Antibody (Myc.A7) [NBP2-37822] - Analysis using the DyLight 680 conjugate of NBP2-37822. Detection of Myc Epitope Tag was performed by loading various amounts of E. coli lysate containing a multi-epitope tagged protein per well onto a 4-20% Tris-HCl polyacrylamide gel. Proteins were transferred to a PVDF membrane and blocked with 5% BSA/TBST for at least 1 hour. The membrane was probed with a DyLight 680-conjugated Myc Epitope Tag monoclonal antibody at a dilution of 1:1000 for 1 hour at room temperature on a rocking platform and washed in TBS-0.1% Tween-20. Detection was performed using the LI-COR Odyssey.](http://images.novusbio.com/fullsize/c-Myc-Antibody-Myc-A7-Western-Blot-NBP2-37822-img0010.jpg)
![Immunocytochemistry/Immunofluorescence: c-Myc Antibody (Myc.A7) [NBP2-37822] - Analysis using the DyLight 488 conjugate of NBP2-37822. Staining of HeLa cells transfected with a construct containing a Myc Epitope Tag. Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature.](http://images.novusbio.com/fullsize/c-Myc-Antibody-Myc-A7-Immunocytochemistry-Immunofluorescence-NBP2-37822-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: c-Myc Antibody (Myc.A7) [NBP2-37822] - Analysis using the DyLight 550 conjugate of NBP2-37822. Staining of HeLa cells transfected with a construct containing a Myc Epitope Tag. Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at](http://images.novusbio.com/fullsize/c-Myc-Antibody-Myc-A7-Immunocytochemistry-Immunofluorescence-NBP2-37822-img0008.jpg)
![Flow Cytometry: c-Myc Antibody (Myc.A7) [NBP2-37822] - An intracellular stain was performed on HepG2 cells with c-Myc Antibody (Myc.A7) NBP2-37822AF488 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 10 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 488.](http://images.novusbio.com/fullsize/c-Myc-Antibody-Myc-A7-Flow-Cytometry-NBP2-37822-img0012.jpg)
![Western Blot: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Neprilysin/CD10.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Western-Blot-NBP2-45817-img0010.jpg "Western Blot: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Neprilysin/CD10.")
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Carcinoma of Human bladder tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0009.jpg)
![Flow Cytometry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - analysis of living 293T cells transfected with MME overexpression plasmid .](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Flow-Cytometry-NBP2-45817-img0011.jpg)
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Human liver tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0001.jpg)
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0002.jpg)
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0003.jpg)
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0004.jpg)
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0005.jpg)
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Carcinoma of Human thyroid tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0006.jpg)
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0007.jpg)
![Immunohistochemistry: Neprilysin/CD10 Antibody (OTI3D11) [NBP2-45817] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-OTI3D11-Immunohistochemistry-NBP2-45817-img0008.jpg)
![Immunohistochemistry-Paraffin: CD31/PECAM-1 Antibody (CO.3E-1D4) [NB100-65900] - Valvular endothelial cell (VEC) markers. Sections of the sheep aortic valve leaflet stained with antibodies against the endothelial cell markers CD31/PECAM-1, CD34, VE-Cadherin (CD144), or von Willebrand Factor (vWF). Represented are the aortic wall and a section of the valvular leaflet (near the free edge), with](http://images.novusbio.com/fullsize/CD31-PECAM-1-Antibody-CO-3E-1D4-Immunohistochemistry-Paraffin-NB100-65900-img0007.jpg "Immunohistochemistry-Paraffin: CD31/PECAM-1 Antibody (CO.3E-1D4) [NB100-65900] - Valvular endothelial cell (VEC) markers. Sections of the sheep aortic valve leaflet stained with antibodies against the endothelial cell markers CD31/PECAM-1, CD34, VE-Cadherin (CD144), or von Willebrand Factor (vWF). Represented are the aortic wall and a section of the valvular leaflet (near the free edge), with")
![Flow Cytometry: CD31/PECAM-1 Antibody (CO.3E-1D4) [NB100-65900] - Staining of sheep peripheral blood platelets with Mouse anti Bovine CD31/PECAM-1 Antibody (CO.3E-1D4).](http://images.novusbio.com/fullsize/CD31-PECAM-1-Antibody-CO-3E-1D4-Flow-Cytometry-NB100-65900-img0005.jpg)
![Immunohistochemistry-Frozen: CD31/PECAM-1 Antibody (CO.3E-1D4) [NB100-65900] - Bovine Lung stained with CD31 (green) and DAPI counterstain. Image provided courtesy of Hala Nijmeh, PhD and the PI, Evgenia V. Gerasimovskaya, PhD. Section of Critical Care Medicine, Department of Pediatrics, University of Colorado Anschutz Medical Center.](http://images.novusbio.com/fullsize/CD31-PECAM-1-Antibody-CO-3E-1D4-Immunohistochemistry-Frozen-NB100-65900-img0006.jpg)
![Western Blot: DPP3 Antibody (2D9) [NBP2-01007] Analysis of extracts (35ug) from 9 different cell lines by using anti-DPP3 monoclonal antibody.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Western-Blot-NBP2-01007-img0015.jpg "Western Blot: DPP3 Antibody (2D9) [NBP2-01007] Analysis of extracts (35ug) from 9 different cell lines by using anti-DPP3 monoclonal antibody.")
![Immunohistochemistry-Paraffin: DPP3 Antibody (2D9) [NBP2-01007] - Staining of paraffin-embedded Human prostate tissue using anti-DPP3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Immunohistochemistry-Paraffin-NBP2-01007-img0014.jpg)
![Flow Cytometry: DPP3 Antibody (2D9) [NBP2-01007] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-DPP3 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Flow-Cytometry-NBP2-01007-img0001.jpg)
![Western Blot: DPP3 Antibody (2D9) [NBP2-01007] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DPP3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DPP3.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Western-Blot-NBP2-01007-img0002.jpg)
![Immunohistochemistry-Paraffin: DPP3 Antibody (2D9) [NBP2-01007] - Staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-DPP3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Immunohistochemistry-Paraffin-NBP2-01007-img0003.jpg)
![Immunohistochemistry-Paraffin: DPP3 Antibody (2D9) [NBP2-01007] - Staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-DPP3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Immunohistochemistry-Paraffin-NBP2-01007-img0004.jpg)
![Immunohistochemistry-Paraffin: DPP3 Antibody (2D9) [NBP2-01007] - Staining of paraffin-embedded Carcinoma of Human liver tissue using anti-DPP3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Immunohistochemistry-Paraffin-NBP2-01007-img0006.jpg)
![Immunohistochemistry-Paraffin: DPP3 Antibody (2D9) [NBP2-01007] - Staining of paraffin-embedded Human lymph node tissue using anti-DPP3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Immunohistochemistry-Paraffin-NBP2-01007-img0011.jpg)
![Immunohistochemistry-Paraffin: DPP3 Antibody (2D9) [NBP2-01007] - Staining of paraffin-embedded Human lymphoma tissue using anti-DPP3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/DPP3-Antibody-2D9-Immunohistochemistry-Paraffin-NBP2-01007-img0012.jpg)
![Western Blot: PCNA Antibody (3D6) [NBP2-46342] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PCNA.](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Western-Blot-NBP2-46342-img0022.jpg "Western Blot: PCNA Antibody (3D6) [NBP2-46342] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PCNA.")
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0021.jpg)
![Western Blot: PCNA Antibody (3D6) [NBP2-46342] - Analysis of extracts (35ug) from 9 different cell lines by using PCNA monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human). Dilution: 1:2000](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Western-Blot-NBP2-46342-img0023.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0001.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0002.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0003.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0004.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0005.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0006.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0007.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0008.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human Ovary tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0009.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0010.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human bladder tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0011.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0012.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0013.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0014.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0015.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0016.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0017.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0018.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0019.jpg)
![Immunohistochemistry: PCNA Antibody (3D6) [NBP2-46342] - Analysis of Carcinoma of Human lung tissue.(Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/PCNA-Antibody-3D6-Immunohistochemistry-NBP2-46342-img0020.jpg)
![Western Blot: BubR1 Antibody (6E5) [NBP1-47680] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BubR1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BubR1.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Western-Blot-NBP1-47680-img0002.jpg "Western Blot: BubR1 Antibody (6E5) [NBP1-47680] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BubR1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BubR1.")
![Immunocytochemistry/Immunofluorescence: BubR1 Antibody (OTI6E5) [NBP1-47680] - BubR1 Antibody (6E5) [NBP1-47680] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY BubR1.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Immunocytochemistry-Immunofluorescence-NBP1-47680-img0012.jpg)
![Immunohistochemistry-Paraffin: BubR1 Antibody (6E5) [NBP1-47680] - Staining of paraffin-embedded prostate tissue using anti-BubR1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Immunohistochemistry-Paraffin-NBP1-47680-img0009.jpg)
![Flow Cytometry: BubR1 Antibody (6E5) [NBP1-47680] - HEK293T cells transfected with either pCMV6-ENTRY BubR1.(Red) or empty vector control plasmid (Blue) were immunostained with anti-BubR1 mouse monoclonal, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Flow-Cytometry-NBP1-47680-img0011.jpg)
![Immunohistochemistry-Paraffin: BubR1 Antibody (6E5) [NBP1-47680] - Staining of paraffin-embedded Adenocarcinoma of breast tissue using anti-BubR1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Immunohistochemistry-Paraffin-NBP1-47680-img0003.jpg)
![Immunohistochemistry-Paraffin: BubR1 Antibody (6E5) [NBP1-47680] - Staining of paraffin-embedded Adenocarcinoma of colon tissue using anti-BubR1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Immunohistochemistry-Paraffin-NBP1-47680-img0004.jpg)
![Immunohistochemistry-Paraffin: BubR1 Antibody (6E5) [NBP1-47680] - Staining of paraffin-embedded Carcinoma of bladder tissue using anti-BubR1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Immunohistochemistry-Paraffin-NBP1-47680-img0005.jpg)
![Immunohistochemistry-Paraffin: BubR1 Antibody (6E5) [NBP1-47680] - Staining of paraffin-embedded colon tissue using anti-BubR1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Immunohistochemistry-Paraffin-NBP1-47680-img0006.jpg)
![Immunohistochemistry-Paraffin: BubR1 Antibody (6E5) [NBP1-47680] - Staining of paraffin-embedded endometrium tissue using anti-BubR1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Immunohistochemistry-Paraffin-NBP1-47680-img0007.jpg)
![Immunohistochemistry-Paraffin: BubR1 Antibody (6E5) [NBP1-47680] - Staining of paraffin-embedded pancreas tissue using anti-BubR1 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/BubR1-Antibody-6E5-Immunohistochemistry-Paraffin-NBP1-47680-img0008.jpg)
![Western Blot: GFAP Antibody (OTI4D11) [NBP1-47782] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY GFAP (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-GFAP.](http://images.novusbio.com/fullsize/GFAP-Antibody-OTI4D11-Western-Blot-NBP1-47782-img0001.jpg "Western Blot: GFAP Antibody (OTI4D11) [NBP1-47782] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY GFAP (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-GFAP.")
![Immunohistochemistry-Paraffin: GFAP Antibody (OTI4D11) [NBP1-47782] - Staining of paraffin-embedded thyroid tissue using anti-GFAP mouse monoclonal antibody.](http://images.novusbio.com/fullsize/GFAP-Antibody-OTI4D11-Immunohistochemistry-Paraffin-NBP1-47782-img0016.jpg)
![Immunohistochemistry-Paraffin: GFAP Antibody (OTI4D11) [NBP1-47782] - Staining of paraffin-embedded Adenocarcinoma of colon tissue using anti-GFAP mouse monoclonal antibody.](http://images.novusbio.com/fullsize/GFAP-Antibody-OTI4D11-Immunohistochemistry-Paraffin-NBP1-47782-img0002.jpg)
![Immunohistochemistry-Paraffin: GFAP Antibody (OTI4D11) [NBP1-47782] - Staining of paraffin-embedded bladder tissue using anti-GFAP mouse monoclonal antibody.](http://images.novusbio.com/fullsize/GFAP-Antibody-OTI4D11-Immunohistochemistry-Paraffin-NBP1-47782-img0004.jpg)
![Immunohistochemistry-Paraffin: GFAP Antibody (OTI4D11) [NBP1-47782] - Staining of paraffin-embedded Kidney tissue using anti-GFAP mouse monoclonal antibody.](http://images.novusbio.com/fullsize/GFAP-Antibody-OTI4D11-Immunohistochemistry-Paraffin-NBP1-47782-img0011.jpg)
![Immunohistochemistry-Paraffin: GFAP Antibody (OTI4D11) [NBP1-47782] - Staining of paraffin-embedded lung tissue using anti-GFAP mouse monoclonal antibody.](http://images.novusbio.com/fullsize/GFAP-Antibody-OTI4D11-Immunohistochemistry-Paraffin-NBP1-47782-img0012.jpg)
![Immunohistochemistry-Paraffin: GFAP Antibody (OTI4D11) [NBP1-47782] - Staining of paraffin-embedded lymph node tissue using anti-GFAP mouse monoclonal antibody.](http://images.novusbio.com/fullsize/GFAP-Antibody-OTI4D11-Immunohistochemistry-Paraffin-NBP1-47782-img0013.jpg)
![Immunohistochemistry-Paraffin: GFAP Antibody (OTI4D11) [NBP1-47782] - Staining of paraffin-embedded prostate tissue using anti-GFAPmouse monoclonal antibody.](http://images.novusbio.com/fullsize/GFAP-Antibody-OTI4D11-Immunohistochemistry-Paraffin-NBP1-47782-img0015.jpg)
![Western Blot: PSMA7 Antibody (3F11) [NBP2-02120] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PSMA7 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PSMA7.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Western-Blot-NBP2-02120-img0002.jpg "Western Blot: PSMA7 Antibody (3F11) [NBP2-02120] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PSMA7 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PSMA7.")
![Immunohistochemistry-Paraffin: PSMA7 Antibody (3F11) [NBP2-02120] Staining of paraffin-embedded thyroid tissue using anti-PSMA7mouse monoclonal antibody.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Immunohistochemistry-Paraffin-NBP2-02120-img0009.jpg)
![Flow Cytometry: PSMA7 Antibody (3F11) [NBP2-02120] - HEK293T cells transfected with either pCMV6-ENTRY PSMA7.(Red) or empty vector control plasmid (Blue) were immunostained with anti-PSMA7 mouse monoclonal, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Flow-Cytometry-NBP2-02120-img0001.jpg)
![Immunohistochemistry-Paraffin: PSMA7 Antibody (3F11) [NBP2-02120] - Staining of paraffin-embedded colon tissue using anti-PSMA7mouse monoclonal antibody.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Immunohistochemistry-Paraffin-NBP2-02120-img0003.jpg)
![Immunohistochemistry-Paraffin: PSMA7 Antibody (3F11) [NBP2-02120] - Staining of paraffin-embedded endometrium tissue using anti-PSMA7 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Immunohistochemistry-Paraffin-NBP2-02120-img0004.jpg)
![Immunohistochemistry-Paraffin: PSMA7 Antibody (3F11) [NBP2-02120] - Staining of paraffin-embedded Kidney tissue using anti-PSMA7mouse monoclonal antibody.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Immunohistochemistry-Paraffin-NBP2-02120-img0005.jpg)
![Immunohistochemistry-Paraffin: PSMA7 Antibody (3F11) [NBP2-02120] - Staining of paraffin-embedded liver tissue using anti-PSMA7mouse monoclonal antibody.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Immunohistochemistry-Paraffin-NBP2-02120-img0006.jpg)
![Immunohistochemistry-Paraffin: PSMA7 Antibody (3F11) [NBP2-02120] - Staining of paraffin-embedded Ovary tissue using anti-PSMA7mouse monoclonal antibody.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Immunohistochemistry-Paraffin-NBP2-02120-img0007.jpg)
![Immunohistochemistry-Paraffin: PSMA7 Antibody (3F11) [NBP2-02120] - Staining of paraffin-embedded prostate tissue using anti-PSMA7mouse monoclonal antibody.](http://images.novusbio.com/fullsize/PSMA7-Antibody-3F11-Immunohistochemistry-Paraffin-NBP2-02120-img0008.jpg)